SCHEMBL16372999

SCHEMBL16372999

COC(=O)[C@@]1(OCCCSCCN)C[C@@H](O)[C@@H](NC(C)=O)C([C@H](O)[C@H](O)CNC(=O)c2ccc(-c3ccccc3)cc2)O1

nearest known ligand 0.76

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ CD22 P20273 5/20 0.76
▸ SIGLEC7 Q9Y286 3/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18357289 1.00 CD22 (0.76) CD22SIGLEC7
SCHEMBL16839996 1.00 CD22 (0.76) CD22SIGLEC7
SCHEMBL16373216 0.95 CD22 (0.73) CD22SIGLEC7
SCHEMBL18357221 0.95 CD22 (0.68) CD22
SCHEMBL16840002 0.95 CD22 (0.68) CD22
SCHEMBL16373254 0.94 CD22 (0.78) CD22SIGLEC7
SCHEMBL15087695 0.94 CD22 (0.78) CD22SIGLEC7
SCHEMBL15087776 0.94 CD22 (0.78) CD22SIGLEC7
SCHEMBL21555926 0.93 CD22 (0.76) CD22SIGLEC7
SCHEMBL16373192 0.93 CD22 (0.76) CD22SIGLEC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9260467-B2 Sialic acid dimers BROSSMER REINHARD (DE) 2016-02-16 — — US disclosed
US-20150005245-A1 Sialic Acid Dimers BROSSMER REINHARD (DE) 2015-01-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150005245-A1 Sialic Acid Dimers SIGLEC9, SIGLEC7, NEU2 CD22 20/4885SIGLEC7 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback